Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg H Waetzig

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 3, 2018
Pharmacological inhibition of IL-6 trans-signaling improves compromised fracture healing after severe traumaKathrin Kaiser, Katja Prystaz, Anna Vikman, et al.
European Journal of Cell Biology|November 2, 2010
The structure of the unliganded extracellular domain of the interleukin-6 signal transducer gp130 in solutionInken Lorenzen, Weifeng Shang, Markus Perbandt, et al.
The Journal of Biological Chemistry|March 22, 2018
The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signalingPaul Baran, Selina Hansen, Georg H Waetzig, et al.
Blood|November 9, 2007
Transgenic blockade of interleukin 6 transsignaling abrogates inflammationBjörn Rabe, Athena Chalaris, Ulrike May, et al.
The Journal of Biological Chemistry|April 24, 2012
Constitutively active mutant gp130 receptor protein from inflammatory hepatocellular adenoma is inhibited by an anti-gp130 antibody that specifically neutralizes interleukin 11 signalingJan Sommer, Timo Effenberger, Elena Volpi, et al.
The Journal of Biological Chemistry|December 5, 2012
An interleukin-6 receptor-dependent molecular switch mediates signal transduction of the IL-27 cytokine subunit p28 (IL-30) via a gp130 protein receptor homodimerChristoph Garbers, Björn Spudy, Samadhi Aparicio-Siegmund, et al.
The Journal of Biological Chemistry|May 3, 2014
A disintegrin and metalloprotease 17 dynamic interaction sequence, the sweet tooth for the human interleukin 6 receptorStefan Düsterhöft, Katharina Höbel, Mirja Oldefest, et al.
The Journal of Biological Chemistry|June 29, 2014
Alternative intronic polyadenylation generates the interleukin-6 trans-signaling inhibitor sgp130-E10Jan Sommer, Christoph Garbers, Janina Wolf, et al.
RNA Biology|September 19, 2015
RAID3--An interleukin-6 receptor-binding aptamer with post-selective modification-resistant affinityFlorian Mittelberger, Cindy Meyer, Georg H Waetzig, et al.
International Journal of Pharmaceutics|April 17, 2019
Adjustment of triple shellac coating for precise release of bioactive substances with different physico-chemical properties in the ileocolonic regionEva-Maria Theismann, Julia Katharina Keppler, Jörg-Rainer Knipp, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 3, 2018
Pharmacological inhibition of IL-6 trans-signaling improves compromised fracture healing after severe traumaKathrin Kaiser, Katja Prystaz, Anna Vikman, et al.
European Journal of Cell Biology|November 2, 2010
The structure of the unliganded extracellular domain of the interleukin-6 signal transducer gp130 in solutionInken Lorenzen, Weifeng Shang, Markus Perbandt, et al.
The Journal of Biological Chemistry|March 22, 2018
The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signalingPaul Baran, Selina Hansen, Georg H Waetzig, et al.
Blood|November 9, 2007
Transgenic blockade of interleukin 6 transsignaling abrogates inflammationBjörn Rabe, Athena Chalaris, Ulrike May, et al.
The Journal of Biological Chemistry|April 24, 2012
Constitutively active mutant gp130 receptor protein from inflammatory hepatocellular adenoma is inhibited by an anti-gp130 antibody that specifically neutralizes interleukin 11 signalingJan Sommer, Timo Effenberger, Elena Volpi, et al.
The Journal of Biological Chemistry|December 5, 2012
An interleukin-6 receptor-dependent molecular switch mediates signal transduction of the IL-27 cytokine subunit p28 (IL-30) via a gp130 protein receptor homodimerChristoph Garbers, Björn Spudy, Samadhi Aparicio-Siegmund, et al.
The Journal of Biological Chemistry|May 3, 2014
A disintegrin and metalloprotease 17 dynamic interaction sequence, the sweet tooth for the human interleukin 6 receptorStefan Düsterhöft, Katharina Höbel, Mirja Oldefest, et al.
The Journal of Biological Chemistry|June 29, 2014
Alternative intronic polyadenylation generates the interleukin-6 trans-signaling inhibitor sgp130-E10Jan Sommer, Christoph Garbers, Janina Wolf, et al.
RNA Biology|September 19, 2015
RAID3--An interleukin-6 receptor-binding aptamer with post-selective modification-resistant affinityFlorian Mittelberger, Cindy Meyer, Georg H Waetzig, et al.
International Journal of Pharmaceutics|April 17, 2019
Adjustment of triple shellac coating for precise release of bioactive substances with different physico-chemical properties in the ileocolonic regionEva-Maria Theismann, Julia Katharina Keppler, Jörg-Rainer Knipp, et al.
Pageof 6